BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12491598)

  • 1. [The relevance of a simultaneous measurement of WBC and CRP as a POCT(point of care testing) of the inflammatory markers running title: the POCT(point of care testing) of WBC and CRP].
    Miyazaki M
    Rinsho Byori; 2002 Nov; 50(11):1029-34. PubMed ID: 12491598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utility of microsemi LC-667CRP in point of care testing system for acute inflammatory disease].
    Inaba T; Yuasa S; Taniguchi H; Nakashima K; Nagaoka H; Fujita N
    Rinsho Byori; 2010 Jul; 58(7):664-9. PubMed ID: 20715509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a new point-of-care testing system for measuring white blood cell and C-reactive protein levels in whole blood samples.
    Kotani K; Minami T; Abe T; Sato J; Taniguchi N; Yamada T
    Clin Chim Acta; 2014 Jun; 433():145-9. PubMed ID: 24642344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Smit JJ; Ottervanger JP; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; Zijlstra F; van 't Hof AW;
    Am J Cardiol; 2008 Feb; 101(4):446-51. PubMed ID: 18312755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exploratory analysis of elevated C-reactive protein without leukocytosis from the clinical laboratory database].
    Ishida H; Ichihara K; Matsuda N
    Rinsho Byori; 2000 Aug; 48(8):722-9. PubMed ID: 11064595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing.
    Oh SW; Moon JD; Park SY; Jang HJ; Kim JH; Nahm KB; Choi EY
    Clin Chim Acta; 2005 Jun; 356(1-2):172-7. PubMed ID: 15936314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Microsemi CRP, an automated hematology analyzer for rapid 3-part WBC differential and CRP using whole blood.
    Nomura N; Saito K; Ikeda M; Yuasa S; Pastore M; Chabert C; Kono E; Sakai A; Tanaka H; Ikemoto T; Takubo T
    Int J Lab Hematol; 2015 Aug; 37(4):466-73. PubMed ID: 25496069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL; Lin JM; Reeves WC
    Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The current method of handling of test samples and medical reimbursement for POCT in Japan].
    Shimetani N
    Rinsho Byori; 2002 Oct; 50(10):958-64. PubMed ID: 12451675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-reactive protein, white blood cell and body temperature following cardiovascular surgery, as predicting factors of postoperative infection].
    Suzuki S; Haga Y; Hashizume K; Murayama A; Ishikawa S; Takahashi A; Kanki H; Kume A; Kuwabara S
    Kyobu Geka; 2006 Dec; 59(13):1146-53. PubMed ID: 17163205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
    Lippi G; Franchini M; Targher G; Poli G; Guidi GC
    Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count.
    Takemura Y; Ebisawa K; Kakoi H; Saitoh H; Kure H; Ishida H; Kure M
    J Clin Pathol; 2005 Jul; 58(7):729-33. PubMed ID: 15976341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive values of serial C-reactive protein in neonatal sepsis.
    Nuntnarumit P; Pinkaew O; Kitiwanwanich S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1151-8. PubMed ID: 12549789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory markers; C-reactive protein (CRP) and serum amyloid A (SAA)].
    Yamada T
    Rinsho Byori; 2005 Jun; 53(6):558-61. PubMed ID: 16026085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of POCT in critical care medicine].
    Fukuda A; Ishida H; Kubota M; Kojima Y
    Rinsho Byori; 1999 Dec; 47(12):1113-8. PubMed ID: 10639820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serum C-reactive protein and leukocyte count in the diagnosis of acute appendicitis in Nepalese population.
    Agrawal CS; Adhikari S; Kumar M
    Nepal Med Coll J; 2008 Mar; 10(1):11-5. PubMed ID: 18700623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein.
    Seamark DA; Backhouse SN; Powell R
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):178-80. PubMed ID: 12662408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.